Department of Health and Social Care (DHSC) has issued a medicine supply notification for Estradiol (Estradot®) 75micrograms/24hours transdermal patches.

MSN/2023/047

Tier 2 – medium impact

Date of issue 13th April 2023

Estradiol (Estradot®) 75micrograms/24hours transdermal patches are out of stock until early May 2023.
An alternative brand of estradiol patches, Evorel®, available as 75micrograms/24hours can support a full uplift in demand.
A Serious Shortage Protocol (SSP) was issued on 13/042023.

A copy of this medicine supply notification, including further information for pharmacy teams, has been sent to all pharmacy NHS email addresses.

DHSC and NHSE/I have now launched an online Medicines Supply Tool, which provides up to date information about medicine supply issues. The contents of these MSNs can now be viewed on the Tool.

The Tool also details any changes to resupply dates and updates to the entries.

To access the Tool you will need  an NHS email address. Once set up and logged in, you will be able to access it online.

New shortages not listed on the SPS website, can be reported using our shortage reporting tool.

The post Medicine Supply Notification: Estradiol (Estradot® ) 75micrograms/24hours transdermal patches appeared first on PSNC Website.